Immunomodulatory effects of low dose chemotherapy and perspectives of combanation with immunotherapy
Carregando...
Data
2011
Autores
Nars, Mariana de Souza [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Editor
Universidade Estadual Paulista (Unesp)
Resumo
Nowadays cancer is one of the main causes of death and many efforts worldwide have been driven to find out new treatments and approaches in order to extinguish or reduce this group of disorder. Chemotherapy is the main treatment for cancer, however, conventional schedule based on maximum tolerated dose (MTD) show several side effects and frequently allow the development of drug resistance. In this review we present the evidence that metronomic chemotherapy, based on the frequent administration of low or intermediate doses of chemotherapeutics is as efficient as MTD and works better in some situations. Finally, we present some data indicating that noncytotoxic concentrations of antineoplastic agents are able to both up-regulate the immune system and increase the susceptibility of tumor cells to cytotoxic T lymphocytes. Taken together, data from the literature provide us the evidence that low concentrations of selected chemotherapeutics agents, rather than conventional high doses, should be chosen for combination with immunotherapy
Não disponível
Não disponível
Descrição
Palavras-chave
Quimioterapia, Imunoterapia, Vacinas, Celulas que apresentam antigenos, Celulas T
Como citar
NARS, Mariana de Souza. Immunomodulatory effects of low dose chemotherapy and perspectives of combanation with immunotherapy. 2011. 1 CD-ROM. Trabalho de conclusão de curso (bacharelado - Ciências Biomédicas) - Universidade Estadual Paulista Júlio de Mesquita Filho, Instituto de Biociências de Botucatu, 2011.